Quantitative MRI Lesion Evolution Mapping from a Single Sequence

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing MRI techniques struggle to accurately quantify and visualize lesion evolution, making it difficult to assess tissue damage severity and compare lesion statuses across patients or over time.

Innovation Solution

A method and system using quantitative MRI (qMRI) to acquire a single MR sequence, generate a lesion evolution model with predetermined sets of quantitative values, and determine lesion evolution values based on voxel comparisons, enabling visualization and monitoring of lesion progression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional MRI techniques are used to detect lesions, then lesion detection is possible, but accurate quantification of lesion evolution and visualization of tissue damage severity is not achieved

Engineering Contradiction:
Improvequantification precisionVSAvoidlesion evolution information
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent transforms conventional qualitative MRI images into quantitative parameters by measuring physical properties (T1 relaxation time, T2 relaxation time, proton density) of tissue voxels. These physical parameters serve as objective indicators of tissue damage severity and lesion evolution, enabling precise quantification that conventional imaging cannot achieve.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the mechanical/visual assessment system with a quantitative measurement system. Instead of relying on visual interpretation of grey-scale images, the system uses automated measurement of physical parameters (relaxation times, proton density) to objectively quantify tissue properties and track lesion evolution over time.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If multiple MR sequences are acquired to obtain quantitative information, then measurement precision improves, but scanning time and complexity increase

Engineering Contradiction:
Improvequantitative information accuracyVSAvoidscanning time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent designs a single MR sequence that simultaneously acquires multiple quantitative parameters (T1, T2, and proton density) from the same data. This multi-functional sequence eliminates the need for separate acquisition protocols for each parameter, reducing total scanning time while maintaining comprehensive quantitative information.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent combines multiple measurement objectives into a single MR sequence acquisition. By merging the acquisition of T1, T2, and proton density information into one sequence, the system reduces the number of separate scanning operations required, thereby decreasing overall scanning time and complexity.

Inventive Principle:
Principle #5Merging (Combining)

3Loss of information

If grey scale MR images are used to assess tissue damage, then visualization is possible, but detailed information about lesion evolution and severity is insufficient

Engineering Contradiction:
Improvetissue damage informationVSAvoidimage processing complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The patent replaces the visual interpretation system with a quantitative measurement system. Instead of relying on subjective visual assessment of grey-scale images, the system automatically measures physical parameters (T1, T2 relaxation times, proton density) to objectively quantify tissue damage severity and track evolution, reducing the complexity of manual analysis.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces quantitative parameters (T1, T2, proton density values) as intermediaries between the raw MRI data and the clinical assessment. These physical parameters serve as objective mediators that translate complex image data into measurable tissue properties, simplifying the assessment process while providing detailed information about lesion evolution.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates fast and reliable quantification and visualization of lesion evolution, allowing for effective treatment evaluation and comparison across patients, with enhanced monitoring capabilities.

Implementation Method 1

The MRI techniques are generally based on relaxation properties of excited hydrogen nuclei (protons) of an object under test. When the object to be imaged is placed in a powerful, uniform magnetic field of the MRI scanner, the spins of the atomic nuclei of water in the object with non-integer spin numbers within the object all align either parallel or anti-parallel to the magnetic field.

Methodology Applied
Scientific EffectNuclear magnetic resonance:

Implementation Method 2

the magnetization vector slowly relaxes towards its equilibrium orientation that is parallel to the magnetic field by a time constant called longitudinal relaxation time (T1). A longitudinal relaxation rate R1 is the reciprocal of the longitudinal relaxation time T1 (R1=1/T1).

Methodology Applied
Scientific EffectLongitudinal relaxation:

Implementation Method 3

The loss of coherence of the spin system attenuates the MRI signal with a time constant called a transverse relaxation time (T2).

Methodology Applied
Scientific EffectTransverse relaxation:

Data Source

PatentUS20250352082A1Method and system of quantifying lesion evolution
Publication Date: 2025.11.20 SYNTHETICMR AB PUBL
  • US20250352082A1 patent drawing
  • US20250352082A1 patent drawing
  • US20250352082A1 patent drawing

AI summary

A method of quantifying lesion evolution, comprising: acquiring, at a first time point, by a magnetic resonance, MR, scanning device, a single MR sequence of a portion of a body, the single MR sequence comprising quantitative information of the portion; generating, by a processing circuit, a first MR image representing the portion, based on the single MR sequence, wherein each voxel of the first MR image represents a corresponding volume of the portion; providing a lesion evolution model comprising at least two predetermined sets of quantitative values, wherein each of the at least two predetermined sets of quantitative values is associated with a reference lesion evolution value indicating a status of lesion evolution; for a voxel of a region of interest of the first MR image, determining, by the processing circuit, a lesion evolution value of said voxel, indicating a status of lesion evolution at the first time point.